Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.240
-0.010 (-0.80%)
At close: Sep 25, 2026, 4:00 PM EDT
1.254
+0.014 (1.13%)
Pre-market: Sep 28, 2026, 7:05 AM EDT
Caribou Biosciences Employees
Caribou Biosciences had 97 employees as of December 31, 2025. The number of employees decreased by 50 or -34.01% compared to the previous year.
Employees
97
Change (1Y)
-50
Growth (1Y)
-34.01%
Revenue / Employee
$103,454
Profits / Employee
-$1,066,010
Market Cap
132.94M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 97 | -50 | -34.01% |
| Dec 31, 2024 | 147 | -11 | -6.96% |
| Dec 31, 2023 | 158 | 21 | 15.33% |
| Dec 31, 2022 | 137 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immunic | 100 |
| enGene Therapeutics | 82 |
| Tenaya Therapeutics | 70 |
| Neumora Therapeutics | 63 |
| Armata Pharmaceuticals | 61 |
| Corbus Pharmaceuticals Holdings | 36 |
| TuHURA Biosciences | 22 |
| Unicycive Therapeutics | 22 |
CRBU News
- 6 weeks ago - Caribou Biosciences reports Q2 EPS (24c), consensus (31c) - TheFly
- 6 weeks ago - Caribou Biosciences price target lowered to $5 from $6 at BofA - TheFly
- 6 weeks ago - Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Caribou Biosciences Quarterly report: Q2 2026 - Filings
- 6 weeks ago - Caribou Biosciences Earnings release: Q2 2026 - Filings
- 2 months ago - Caribou Biosciences Transcript: H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - Transcripts
- 3 months ago - Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - GlobeNewsWire
- 3 months ago - Caribou Biosciences Transcript: AGM 2026 - Transcripts